US Stock MarketDetailed Quotes

INBX Inhibrx Biosciences

Watchlist

12.980
-0.930-6.69%

Close Jul 18 16:00 ET

187.90MMarket Cap-1141P/E (TTM)

Inhibrx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Receivables

--304K

202.72%778K

--257K

-Accounts receivable

--171K

220.16%778K

--243K

-Related party accounts receivable

----

--0

--14K

-Other receivables

--133K

----

----

Prepaid assets

--13.34M

111.52%12.32M

--5.83M

Other current assets

--539K

102.21%366K

--181K

Total current assets

--14.18M

114.99%13.47M

--6.26M

Non current assets

Net PPE

--9.7M

29.83%9.37M

--7.22M

-Gross PPE

--16.73M

25.87%16.06M

--12.76M

-Accumulated depreciation

---7.03M

-20.70%-6.69M

---5.54M

Related parties assets

----

--0

--14K

Non current prepaid assets

--4.34M

----

----

Other non current assets

----

0.00%3.16M

--3.16M

Total non current assets

--14.04M

20.74%12.54M

--10.38M

Total assets

--28.22M

56.20%26M

--16.65M

Liabilities

Current liabilities

Payables

--12.37M

91.37%8.31M

--4.34M

-accounts payable

--12.37M

91.37%8.31M

--4.34M

Current accrued expenses

--21.85M

42.77%15.98M

--11.2M

Current debt and capital lease obligation

--2.12M

10.91%2.06M

--1.86M

-Current capital lease obligation

--2.12M

10.91%2.06M

--1.86M

Current liabilities

--38.43M

58.21%32.86M

--20.77M

Non current liabilities

Long term debt and capital lease obligation

--561K

-65.02%1.11M

--3.17M

-Long term capital lease obligation

--561K

-65.02%1.11M

--3.17M

Total non current liabilities

--561K

-65.02%1.11M

--3.17M

Total liabilities

--38.99M

41.88%33.97M

--23.95M

Shareholders'equity

Other equity interest

---10.77M

-9.22%-7.97M

---7.3M

Total stockholders'equity

---10.77M

-9.22%-7.97M

---7.3M

Total equity

---10.77M

-9.22%-7.97M

---7.3M

Currency Unit

USD

USD

USD

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Receivables	--304K	202.72%778K	--257K
-Accounts receivable	--171K	220.16%778K	--243K
-Related party accounts receivable	----	--0	--14K
-Other receivables	--133K	----	----
Prepaid assets	--13.34M	111.52%12.32M	--5.83M
Other current assets	--539K	102.21%366K	--181K
Total current assets	--14.18M	114.99%13.47M	--6.26M
Non current assets
Net PPE	--9.7M	29.83%9.37M	--7.22M
-Gross PPE	--16.73M	25.87%16.06M	--12.76M
-Accumulated depreciation	---7.03M	-20.70%-6.69M	---5.54M
Related parties assets	----	--0	--14K
Non current prepaid assets	--4.34M	----	----
Other non current assets	----	0.00%3.16M	--3.16M
Total non current assets	--14.04M	20.74%12.54M	--10.38M
Total assets	--28.22M	56.20%26M	--16.65M
Liabilities
Current liabilities
Payables	--12.37M	91.37%8.31M	--4.34M
-accounts payable	--12.37M	91.37%8.31M	--4.34M
Current accrued expenses	--21.85M	42.77%15.98M	--11.2M
Current debt and capital lease obligation	--2.12M	10.91%2.06M	--1.86M
-Current capital lease obligation	--2.12M	10.91%2.06M	--1.86M
Current liabilities	--38.43M	58.21%32.86M	--20.77M
Non current liabilities
Long term debt and capital lease obligation	--561K	-65.02%1.11M	--3.17M
-Long term capital lease obligation	--561K	-65.02%1.11M	--3.17M
Total non current liabilities	--561K	-65.02%1.11M	--3.17M
Total liabilities	--38.99M	41.88%33.97M	--23.95M
Shareholders'equity
Other equity interest	---10.77M	-9.22%-7.97M	---7.3M
Total stockholders'equity	---10.77M	-9.22%-7.97M	---7.3M
Total equity	---10.77M	-9.22%-7.97M	---7.3M
Currency Unit	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

Recent IPOs